Teva announces top-line results from GALA Phase III trial
14 June 2012 | By Teva Pharmaceutical Industries Ltd
Teva announced positive top-line results from the GALA Phase III clinical trial assessing the efficacy, safety and tolerability...
List view / Grid view
News
Lundbeck plans to establish a more flexible commercial organisation in Europe
14 June 2012 | By H. Lundbeck A/S
Lundbeck proposes to restructure its commercial organisation in Europe to build a more flexible commercial infrastructure and to maintain cost control...
Cellectricon presented advanced cell-based assay systems at ELA 2012
13 June 2012 | By Alto Marketing
Speeding up research with novel cell manipulation and analysis platforms...
Syrris established as market leader in flow chemistry
13 June 2012 | By kdm communications limited
Syrris becomes the leading supplier of flow chemistry solutions around the world...
Lonza and Biowa sign license agreements with FivePrime Therapeutics
Five Prime Therapeutics, Inc. (“FivePrime”) has entered into research and commercial agreements with BioWa, Inc. and Lonza to use their POTELLIGENT® CHOK1SV Cell Line for the research, development and production of multiple proprietary antibodies in FivePrime’s oncology pipeline.
JDRF and Novo Nordisk establish R&D collaboration in type 1 diabetes
13 June 2012 | By Novo Nordisk
Focus will be on disease-modifying immunotherapies for type 1 diabetes...
Sanofi voted leading Pan-European Quoted Company for Investor Relations
13 June 2012 | By Sanofi
Sanofi granted the award for “Leading Pan-European Quoted Company for Investor Relations”...
New Phase III data showed Merck’s investigational insomnia medicine suvorexant improved patients’ ability to fall asleep and stay asleep
13 June 2012 | By Merck
New data from two pivotal Phase III trials...
Project HOPE Presents Dr. Lechleiter, Lilly with Global Health Partner Award
12 June 2012 | By Eli Lilly and Company
Inaugural award recognizes life-changing impact of 53-year partnership...
Global survey finds one in four type 2 diabetes patients do not take basal insulin as prescribed
12 June 2012 | By
One in four people with type 2 diabetes did not dose their long-acting (basal) insulin correctly...
Lilly expands strategic partnership with Novast to serve chinese patients with high-quality branded generic medicines
12 June 2012 | By Eli Lilly and Company
Lilly will increase equity position in Novast by $20 million...
Amgen completes acquisition of Mustafa Nevzat Pharmaceuticals
12 June 2012 | By Amgen
Amgen announced the completion of the acquisition of more than 99 percent of the shares of Mustafa Nevzat Pharmaceuticals...
Genzyme submits applications to FDA and EMA for approval of LEMTRADA™ (alemtuzumab) for multiple sclerosis
12 June 2012 | By Sanofi
Genzyme is developing LEMTRADA in MS in collaboration with Bayer HealthCare...
New epidemiological data provide additional safety evidence for Lantus®
11 June 2012 | By Sanofi
New results of a large-scale epidemiological program announced...
Stiefel signs worldwide acquisition and license agreement for Toctino®
11 June 2012 | By GlaxoSmithKline
Stiefel has entered into a worldwide agreement to acquire Toctino (alitretinoin) from Basilea Pharmaceutica Ltd...
